BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30320416)

  • 1. What makes D-dimer assays suspicious-heterophilic antibodies?
    Wu Y; Xiao YX; Huang TY; Zhang XY; Zhou HB; Zhang XX; Wu YE
    J Clin Lab Anal; 2019 Feb; 33(2):e22687. PubMed ID: 30320416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterophilic antibody interference in immunometric assays.
    Bolstad N; Warren DJ; Nustad K
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):647-61. PubMed ID: 24094636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Falsely elevated D-dimer partially caused by heterophilic antibodies: A case report.
    Ma H; Chen CH; Li YM; Wang JJ; Hu ZD
    Clin Chim Acta; 2022 Oct; 535():140-142. PubMed ID: 35988779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera.
    Bolstad N; Warren DJ; Bjerner J; Kravdal G; Schwettmann L; Olsen KH; Rustad P; Nustad K
    Clin Chem Lab Med; 2011 Sep; 49(12):2001-6. PubMed ID: 21899496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference from heterophilic antibodies in D-dimer assessment. A case report.
    Lippi G; Ippolito L; Tondelli MT; Favaloro EJ
    Blood Coagul Fibrinolysis; 2014 Apr; 25(3):277-9. PubMed ID: 24253242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoassay interference caused by heterophilic antibodies interacting with biotin.
    Vos MJ; Rondeel JMM; Mijnhout GS; Endert E
    Clin Chem Lab Med; 2017 May; 55(6):e122-e126. PubMed ID: 27754962
    [No Abstract]   [Full Text] [Related]  

  • 7. A Case of False Elevation of D-Dimer and Elimination Methods.
    Yu D; Tong H
    Clin Lab; 2024 Jun; 70(6):. PubMed ID: 38868870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference of D-dimer levels from heterophilic antibody in COVID-19: A serious concern in treatment and follow-up of patients.
    Ozbalci D; Doguc DK; Yilmaz G; Ozturk O; Sirin FB; Akcam FZ
    Int J Lab Hematol; 2022 Feb; 44(1):e13-e16. PubMed ID: 34191392
    [No Abstract]   [Full Text] [Related]  

  • 9. Interference of circulating endogenous antibodies on the Dimension® DGNA digoxin immunoassay: elimination with a heterophilic blocking reagent.
    Hermida-Cadahía EF; Calvo MM; Tutor JC
    Clin Biochem; 2010 Dec; 43(18):1475-7. PubMed ID: 20875811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the enhanced Abbott AxSYM cardiac troponin I reagent in patients with heterophilic antibodies.
    Yeo KT; Storm CA; Li Y; Jayne JE; Brough T; Quinn-Hall KS; Fitzmaurice TF
    Clin Chim Acta; 2000 Feb; 292(1-2):13-23. PubMed ID: 10686273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference from heterophilic antibodies in troponin testing. Case report and systematic review of the literature.
    Lippi G; Aloe R; Meschi T; Borghi L; Cervellin G
    Clin Chim Acta; 2013 Nov; 426():79-84. PubMed ID: 24041812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation, calibration, and specificity of quantitative D-dimer assays.
    Dempfle CE
    Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterophilic antibody interference in a tryptase immunoassay.
    van Toorenenbergen AW; Hooijkaas H; Heerenbrink GK; Dufour-van den Goorbergh DM
    Clin Biochem; 2008 Mar; 41(4-5):331-4. PubMed ID: 18054333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine heterophilic antibodies as a source of false-positive B-type natriuretic peptide sandwich ELISA results.
    Solter PF; Oyama MA; Sisson DD
    Vet Clin Pathol; 2008 Mar; 37(1):86-95. PubMed ID: 18366550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterophilic antibody interference in a non-endogenous molecule assay: an apparent elevation in the tacrolimus concentration.
    Altinier S; Varagnolo M; Zaninotto M; Boccagni P; Plebani M
    Clin Chim Acta; 2009 Apr; 402(1-2):193-5. PubMed ID: 19150346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A diagnostic conundrum: heterophilic antibody interference in an adrenocorticotropic hormone immunoassay not detectable using a proprietary heterophile blocking reagent.
    Grasko J; Willliams R; Beilin J; Glendenning P; Fermoyle S; Vasikaran S
    Ann Clin Biochem; 2013 Sep; 50(Pt 5):433-7. PubMed ID: 23873871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterophilic antibodies remain a problem for the immunoassay laboratory.
    Ward G; McKinnon L; Badrick T; Hickman PE
    Am J Clin Pathol; 1997 Oct; 108(4):417-21. PubMed ID: 9322595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo assay.
    Lavoie S; Caswell D; Gill MJ; Kadkhoda K; Charlton CL; Levett PN; Hatchette T; Garceau R; Maregmen J; Mazzulli T; Needle R; Kadivar K; Kim J
    J Clin Virol; 2018 Jul; 104():23-28. PubMed ID: 29704735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor.
    Todd DJ; Knowlton N; Amato M; Frank MB; Schur PH; Izmailova ES; Roubenoff R; Shadick NA; Weinblatt ME; Centola M; Lee DM
    Arthritis Rheum; 2011 Apr; 63(4):894-903. PubMed ID: 21305505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Discrepancy between two methods of D-dimers measurement: one case of human anti-mouse antibody interference].
    Rouvière JA; Devignes J; de Maistre E; Kennel A; Chabot F; Lecompte T
    Ann Biol Clin (Paris); 2008; 66(4):441-6. PubMed ID: 18725347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.